USANA Health Sciences, Inc.
USNA
$27.27
-$0.28-1.02%
NYSE
06/28/2025 | 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | |
---|---|---|---|---|---|
Net Income | 9.66M | 9.40M | 4.45M | 10.61M | 10.43M |
Total Depreciation and Amortization | 9.60M | 10.25M | 5.88M | 5.56M | 5.70M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -2.57M | 5.33M | 948.00K | 4.77M | -3.54M |
Change in Net Operating Assets | -4.48M | -9.50M | -5.50M | 8.59M | -4.60M |
Cash from Operations | 12.22M | 15.48M | 5.79M | 29.53M | 7.99M |
Capital Expenditure | -5.03M | -2.80M | -1.80M | -2.40M | -2.67M |
Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 61.00K | 0.00 |
Cash Acquisitions | -- | -- | -203.34M | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 865.00K | -1.07M | 0.00 | 0.00 | 1.13M |
Cash from Investing | -4.16M | -3.88M | -205.14M | -2.34M | -1.55M |
Total Debt Issued | 1.60M | -- | 23.00M | -2.00K | 154.00K |
Total Debt Repaid | -24.60M | -- | 6.00K | 3.00K | -1.48M |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -15.23M | -14.47M | -74.00K | -79.00K | -31.00K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -379.00K | -- | -- | -- | -- |
Cash from Financing | -38.61M | -14.47M | 22.93M | -78.00K | -1.35M |
Foreign Exchange rate Adjustments | 2.31M | 719.00K | -6.81M | 5.45M | -1.02M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -28.24M | -2.14M | -183.23M | 32.57M | 4.07M |